{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "C",
          "alt": "G",
          "position": "289"
        },
        "variant_string_id": "PARK2 C289G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin is involved in mitophagy, and mutations in PARK2 cause autosomal recessive juvenile onset Parkinsonism. The C289G variant leads to Parkin aggregation and loss of mitophagy function.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 2: Evaluate the assay's applicability",
          "extracted_paper_info": "The study uses a cell-based rescue assay (HSJ1a/DNAJB6 expression) to restore Parkin function, directly modeling the disease mechanism (mitophagy failure due to Parkin aggregation).",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3a: Basic controls/replicates",
          "extracted_paper_info": "The paper does not explicitly state that both wild-type and mutant controls were used, nor does it report statistical replication of experiments (e.g., n-values).",
          "judgment": "No"
        },
        {
          "step_name": "Step 3b: Accepted/validated assay",
          "extracted_paper_info": "The use of molecular chaperones to rescue protein function is a standard approach in the field, though the paper does not cite prior validation or commercial kits for this specific assay.",
          "judgment": "Yes"
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "The paper does not mention using other known pathogenic or benign variants as controls in this assay.",
          "judgment": "No"
        },
        {
          "step_name": "Step 4a: Statistical analyses",
          "extracted_paper_info": "The paper does not report OddsPath values, p-values, or effect sizes for the C289G variant's rescue by HSJ1a/DNAJB6.",
          "judgment": "No"
        },
        {
          "step_name": "Step 4b: No OddsPath calculation",
          "extracted_paper_info": "Only the C289G variant is discussed in the context of this assay; no other pathogenic/benign variants are explicitly used as controls.",
          "judgment": "Total controls: 0 (less than 10)"
        }
      ],
      "final_evidence_strength": "PS3_supporting",
      "overall_conclusion": "The C289G variant in PARK2 is pathogenic, as its loss-of-function phenotype (mitophagy failure) is rescued by molecular chaperones. However, the evidence is limited to a single variant and lacks replication or OddsPath quantification, resulting in 'PS3_supporting' strength."
    }
  ]
}